MCL1 and acute myeloid leukemia: MCL-1 has been shown to play a significant role in promoting cell survival in AML cell lines (64), and its overexpression in tumor cells may be associated with resistance to radiotherapy, chemotherapy, and BH3-mimetics targeting BCL-2/BCL-XL (65–67).